The 20 Best Myelofibrosis Doctors Near Me in Raleigh, NC

Ruben Mesa is a Hematologist and an Oncologist practicing medicine in Charlotte, North Carolina. Dr. Mesa is rated as an Elite provider by MediFind in the treatment of Myelofibrosis. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Myelofibrosis, Polycythemia Vera, Myeloproliferative Neoplasms (MPN), Bone Marrow Transplant, and Splenectomy. Dr. Mesa is board certified in American Board Of Internal Medicine, Hematology. Dr. Mesa is currently accepting new patients.

Uday Popat is a Hematologist practicing medicine in Cary, North Carolina. Dr. Popat is rated as an Elite provider by MediFind in the treatment of Myelofibrosis. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Myelofibrosis, Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Bone Marrow Aspiration.

Prithviraj Bose is a Hematologist practicing medicine in Cary, North Carolina. Dr. Bose is rated as an Elite provider by MediFind in the treatment of Myelofibrosis. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Myelofibrosis, Essential Thrombocythemia, Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant.

Michael Grunwald is a Hematologist and an Oncologist practicing medicine in Charlotte, North Carolina. Dr. Grunwald is rated as a Distinguished provider by MediFind in the treatment of Myelofibrosis. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Polycythemia Vera, Acute Myeloid Leukemia (AML), Acute Promyelocytic Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Grunwald is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine, Medical Oncology, and American Board Of Internal Medicine, Hematology. Dr. Grunwald is currently accepting new patients.

I have the privilege of caring for patients with various myeloproliferative neoplasms including, polycythemia vera, essential thrombocytosis, primary myelofibrosis, systemic mastocytosis, and chronic myeloid leukemia. My goal is to provide the best possible care for each individual patient in an era where the number of therapeutic options for patients with myeloproliferative neoplasms is rapidly expanding. As a clinical investigator leading several clinical studies in both early and late stages of development, I strive to offer patients access to investigational agents with novel mechanisms of action via participation in clinical trials. I believe that every patient has a unique diagnosis and personal experience with their cancer. I aim to consider the disease, the patient and individual care goals in partnering with patients to develop and implement personalized treatment plans. Dr. Rein is rated as a Distinguished provider by MediFind in the treatment of Myelofibrosis. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Systemic Mastocytosis, Myelofibrosis, Myeloproliferative Neoplasms (MPN), Acute Myeloid Leukemia (AML), and Bone Marrow Aspiration. Dr. Rein is board certified in American Board Of Internal Med, Medical Oncology and American Board Of Internal Med, Hematology.

Murat Arcasoy is a Hematologist practicing medicine in Durham, North Carolina. Dr. Arcasoy is rated as a Distinguished provider by MediFind in the treatment of Myelofibrosis. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Essential Thrombocythemia, Polycythemia Vera, Myelofibrosis, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Bone Marrow Aspiration.

I entered medical school for the sole purpose of learning more about human diseases, so that I could focus my laboratory efforts on improving the human condition. However, I was surprised to find myself drawn to clinical care. I care for people afflicted by acute leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms. In this role, I have had the privilege of treating people facing life-threatening illnesses. I strive to gain the trust of each of my patients, so that I can help them make difficult treatment decisions. I engage in clinical research, evaluating novel agents that directly target the cancer cell to improve the degree of success in treating this illness. My patients benefit from my understanding of the newest available treatments, and also have access to promising investigational agents, when appropriate. In my faculty position at Duke University, I enjoy educating current oncologists as well as the next generation of physicians. Dr. Erba is rated as an Advanced provider by MediFind in the treatment of Myelofibrosis. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Erba is board certified in American Board Of Internal Med, Hematology.

I study disorders of the bone marrow and bone marrow failure syndromes. I also see some leukemias and lymphomas and other blood malignancies. Duke offers a very personalized, individualized level of care to each patient. Nobody is the same, so we take the whole patient, we listen to them, and we offer our best recommendations for treatment options. We offer some of the latest treatment options that are available, usually in the setting of a clinical trial. If not, we offer the latest advancement in the field. When I was going through medical school, molecular biology was the new field. Everything was being described as a new cancer-causing gene. And to me that was so appealing – we’re going to figure out what causes cancer and new ways to treat it. That’s what really brought me into the hematology oncology world – things were being discovered that were new and exciting and hopefully would lead to new treatment options. Duke offers an extremely high standard of care. Though we’re not always successful and the disease sometimes wins, our goal is to give the patients the best possible care. Dr. De Castro Iii is rated as an Advanced provider by MediFind in the treatment of Myelofibrosis. He is also highly rated in 46 other conditions, according to our data. His clinical expertise encompasses Paroxysmal Nocturnal Hemoglobinuria (PNH), Aplastic Anemia, Acute Myeloblastic Leukemia without Maturation, Acute Myeloid Leukemia (AML), and Bone Marrow Aspiration. Dr. De Castro Iii is board certified in American Board Of Internal Med, Internal Medicine.

Mauricio Pineda is a Hematologist and an Oncologist practicing medicine in Concord, North Carolina. Dr. Pineda is rated as an Advanced provider by MediFind in the treatment of Myelofibrosis. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Hairy Cell Leukemia (HCL), Childhood Iron Deficiency Anemia, and Myelodysplastic Syndrome (MDS). Dr. Pineda is board certified in American Board Of Internal Medicine, Medical Oncology. Dr. Pineda is currently accepting new patients.

Aleksander Chojecki is a Hematologist and an Oncologist practicing medicine in Charlotte, North Carolina. Dr. Chojecki is rated as an Advanced provider by MediFind in the treatment of Myelofibrosis. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Childhood Acute Myeloid Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Chojecki is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine, Hematology, and American Board Of Internal Medicine, Medical Oncology. Dr. Chojecki is currently accepting new patients.

Greg Knight is a Hematologist and an Oncologist practicing medicine in Charlotte, North Carolina. Dr. Knight is rated as an Advanced provider by MediFind in the treatment of Myelofibrosis. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Knight is board certified in American Board Of Internal Medicine. Dr. Knight is currently accepting new patients.

Tapan Kadia is a Hematologist practicing medicine in Cary, North Carolina. Dr. Kadia is rated as a Distinguished provider by MediFind in the treatment of Myelofibrosis. He is also highly rated in 40 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Prolymphocytic Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant.

Brandi Reeves is a Hematologist practicing medicine in Chapel Hill, North Carolina. Dr. Reeves is rated as a Distinguished provider by MediFind in the treatment of Myelofibrosis. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Polycythemia Vera, Essential Thrombocythemia, Bone Marrow Aspiration, and Bone Marrow Transplant.

Guilin Tang is a Hematologist practicing medicine in Cary, North Carolina. Dr. Tang is rated as a Distinguished provider by MediFind in the treatment of Myelofibrosis. She is also highly rated in 38 other conditions, according to our data. Her clinical expertise encompasses Leukemia, Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Graft.

Patricia Kropf is a Hematologist practicing medicine in Charlotte, North Carolina. Dr. Kropf is rated as an Experienced provider by MediFind in the treatment of Myelofibrosis. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration.

I focus on treating patients with blood cancers who are considering stem cell or bone marrow transplantation. There have been significant improvements in transplantation over the last 20 years, which has improved outcomes. These improvements include the ability to use lower doses of chemotherapy to reduce toxicity for patients, as well as strategies to reduce the risk of relapse. I am interested in using new therapies and approaches to improve outcomes after stem cell transplantation for blood cancers. It is important to work together with patients to determine their goals for treatment and select the best path forward. I have enjoyed working with patients and their families for many years after their transplant. Dr. Alyea is rated as an Experienced provider by MediFind in the treatment of Myelofibrosis. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Acute Myeloblastic Leukemia without Maturation, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia with Maturation, and Bone Marrow Transplant. Dr. Alyea is board certified in American Board Of Internal Med, Medical Oncology.

Jing Ai is a Hematologist and an Oncologist practicing medicine in Charlotte, North Carolina. Dr. Ai is rated as an Experienced provider by MediFind in the treatment of Myelofibrosis. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Childhood Acute Myeloid Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Ai is board certified in American Board Of Internal Medicine. Dr. Ai is currently accepting new patients.

People in need of a bone marrow transplantation can often be scared or intimidated by what is ahead of them -- my goal, when seeing a new patient, is to devote all the time and effort that is needed to address these emotions. My hope is that after this visit, my patient will feel reassured and hopeful that the Duke team of providers will do all that it can to restore them to health, and allow them to return to their lives. Dr. Horwitz is rated as an Experienced provider by MediFind in the treatment of Myelofibrosis. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Graft. Dr. Horwitz is board certified in American Board Of Internal Med, Medical Oncology.

David Rizzieri is an Oncologist practicing medicine in Charlotte, North Carolina. Dr. Rizzieri is rated as an Experienced provider by MediFind in the treatment of Myelofibrosis. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Marrow Aspiration.

Since studying basic immunology prior to beginning my clinical training, I have been deeply interested in applying immunological perspective for the treatment of cancers including hematologic malignancies. Interestingly emerging immunotherapies showed very promising results in recent years. In my clinic, I treat patients with multiple myeloma which is one type of cancer arising from plasma cells. My research will focus on developing early phase clinical protocols utilizing novel cellular therapy approach and also improving the outcomes of blood and marrow transplantation. My ultimate goal is to provide better treatment options than the current standard approach to patients. Dr. Choi is rated as an Experienced provider by MediFind in the treatment of Myelofibrosis. He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Choi is board certified in American Board Of Internal Med, Internal Medicine , American Board Of Internal Med, Medical Oncology , and American Board Of Internal Med, Hematology.